Cox 2 Inhibitors - Toxicology

Relevant Publications

Apigenin attenuates indomethacin-induced gastric ulcer in rats: emphasis on antioxidant, anti-inflammatory, anti-apoptotic, and TGF-β1 enhancing activities.

Issue Release: 2024

Pharmacological insight of rutin as a potential candidate against peptic ulcer.

Issue Release: 2024

Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: a Propensity Score Adjusted Retrospective Cohort Study.

Issue Release: 2024

Clinical efficacy of CDK4/6 inhibitor plus endocrine therapy in HR-positive/HER2-0 and HER2-low-positive metastatic breast cancer: a secondary analysis of PALOMA-2 and PALOMA-3 trials.

Issue Release: 2024

Unveiling Anticancer Potential of COX-2 and 5-LOX Inhibitors: Cytotoxicity, Radiosensitization Potential and Antimigratory Activity against Colorectal and Pancreatic Carcinoma.

Issue Release: 2024

Mortality and major adverse cardiovascular events after glucagon-like peptide-1 receptor agonist initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A population-based study.

Issue Release: 2024

Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study.

Issue Release: 2024

Contribution of non-steroidal anti-inflammatory drugs to breast cancer treatment: and studies.

Issue Release: 2024

[Cardiovascular safety of sitagliptin added to metformin in real world patients with type 2 diabetes].

Issue Release: 2024

Use of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients With Type 2 Diabetes and the Incidence of Retinal Vein Occlusion in Taiwan.

Issue Release: 2024

Malignancy Risk Associated with the Use of Systemic Immunomodulatory Therapy in the Management of Non-infectious Uveitis.

Issue Release: 2024

Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi).

Issue Release: 2024

Identifying alkaline phosphatase inhibitory potential of cyclooxygenase-2 inhibitors: Insights from molecular docking, MD simulations, molecular expression analysis in MCF-7 breast cancer cell line and in vitro investigations.

Issue Release: 2024

In-silico evaluation of Oroxylum indicum vent compounds in the plausible treatment and prevention of nasopharyngeal cancer.

Issue Release: 2024

Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed.

Issue Release: 2024

Imrecoxib: Advances in Pharmacology and Therapeutics.

Issue Release: 2024

Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Following Neoadjuvant Immunochemotherapy in Resectable Stage III Non-Small Cell Lung Cancer Among Chinese Populations: A Multi-Center Retrospective Cohort Study.

Issue Release: 2024

Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.

Issue Release: 2024

CDK4/6 inhibitors and endocrine therapy in the treatment of metastatic breast cancer: A real-world and propensity score-adjusted comparison.

Issue Release: 2024

Association of dipeptidyl peptidase-4 inhibitor initiation at glycated haemoglobin <7.5% with reduced major clinical events mediated by low glycated haemoglobin variability.

Issue Release: 2024

Are There Any Regulations on Phthalates?

Why Do Some Substances Have No Threshold?

Why Are Population Specific Studies Important?

How are Concentration Limits Determined?

What is the Impact on Environmental Health?

How Can QR Codes Enhance Toxicology Research?

What is the Future of 3D Bioprinting in Toxicology?

How do toxicologists assess the safety of a consumer product?

Which Toxins Affect Fibrin Formation?

What are the symptoms of Ketamine overdose?

Cox 2 Inhibitors - Toxicology

Relevant Publications

Partnered Content Networks

Relevant Topics